Literature DB >> 11702846

Malignant transformation of residual endometriosis in women on unopposed oestrogen hormone replacement therapy.

S Lavery1, M Gillmer.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11702846     DOI: 10.1111/j.1471-0528.2001.00238.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  4 in total

Review 1.  Endometriosis: current therapies and new pharmacological developments.

Authors:  Paolo Vercellini; Edgardo Somigliana; Paola Viganò; Annalisa Abbiati; Giussy Barbara; Pier Giorgio Crosignani
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 2.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

3.  Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy.

Authors:  Takashi Uehara; Hiroshi Yoshida; Tomoyasu Kato
Journal:  Gynecol Oncol Rep       Date:  2020-12-28

4.  Clear cell adenocarcinoma arising from abdominal wall endometriosis.

Authors:  Thouraya Achach; Soumaya Rammeh; Amel Trabelsi; Rached Ltaief; Soumaya Ben Abdelkrim; Moncef Mokni; Sadok Korbi
Journal:  J Oncol       Date:  2008-12-21       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.